Your session is about to expire
← Back to Search
Neuropsychological Care for Brain Metastasis
N/A
Recruiting
Led By Joshua D Palmer, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months after radiation therapy
Awards & highlights
Study Summary
This trial is examining the effect of neuropsychological evaluation and intervention on quality of life and cognitive function in cancer patients who have received radiation therapy to the brain.
Who is the study for?
This trial is for English-speaking adults with stage IV solid tumors and brain metastases, who haven't had whole-brain radiation before. They should have a life expectancy of over 6 months. It's not for those with multiple sclerosis, Alzheimer's, dementia, or mental disabilities.Check my eligibility
What is being tested?
The study tests if neuropsychological care by certified experts can help maintain quality of life after radiation therapy in patients with cancer that has spread to the brain. It involves assessments and questionnaires about cognitive function and well-being.See study design
What are the potential side effects?
Since this trial focuses on evaluations rather than medications or invasive treatments, side effects are minimal but may include stress or discomfort from discussing personal health issues during assessments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months after radiation therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months after radiation therapy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quality of life (QOL)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (neuropsychological evaluation)Experimental Treatment3 Interventions
Patients undergo neuropsychological evaluations with a certified neuropsychologist at baseline, 3 months, and 6 months.
Group II: Arm II (usual care)Active Control3 Interventions
Patients receive usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neuropsychological Assessment
2016
N/A
~60
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,120 Total Patients Enrolled
Joshua D Palmer, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
1 Previous Clinical Trials
56 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had whole brain radiation therapy before.My cancer is at stage IV and is a solid tumor.I primarily speak English.My doctor expects me to live more than 6 months.I will receive radiation therapy for cancer that has spread to my brain.
Research Study Groups:
This trial has the following groups:- Group 1: Arm I (neuropsychological evaluation)
- Group 2: Arm II (usual care)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this experiment accessible to participants now?
"Confirmed. According to the clinicaltrials.gov database, this medical study was initially posted on August 30th 2022 and is currently actively recruiting 47 individuals from a single site."
Answered by AI
How many participants is the clinical trial looking to include?
"Affirmative. The clinicaltrials.gov database reveals that this medical trial, which had its inception on August 30th 2022 is actively enrolling patients. 47 people are required to join from a single research site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger